February 4, 2021
In Brief Clinical trials are the scientific way of assessing medications’ efficacy in treating a medical condition and side effects. EMA guidelines for clinical trial regulations […]
Do you like it?
February 1, 2021
In-Brief: The best clinical trial recruitment strategies start by focusing on the patient perspective. From there, it helps to get creative. A reliable clinical trial patient […]
Do you like it?
January 28, 2021
In-Brief: Real-world evidence, which is based on data gathered during routine clinical exercise, has the potential to make a significant impact in nearly every phase of […]
Do you like it?
January 25, 2021
Brief Humans differ in their biological reactions to medical products or drugs but not all adverse reactions associated with the use of medical products can be […]
Do you like it?
January 22, 2021
In-Brief: There are two main parts in medical writing, medical communication and regulatory writing. Pepgra blog focuses on regulatory writing, which involves preparing the clinical study and […]
Do you like it?
January 18, 2021
Brief: Advancements in the medical field and the proliferation of diagnosis and screening tests have to create mountains of data on patient healthcare. Digital information technology […]
Do you like it?
January 18, 2021
In-Brief: Healthcare data analytics solutions provide a powerful approach to understand the spectrum of disease with applications in observational and analytic epidemiology, screening and diagnosis randomized […]
Do you like it?
January 11, 2021
In-Brief: The patient registry is a specific study or a detailed survey of research question or hypothesis generally. Clinical research statistical service is a collection of […]
Do you like it?
January 7, 2021
Brief: Have a look at post-authorization safety studies and important pharmacoepidemiological and pharmacovigilance aspects in clinical research in this Pepgra blog. PASS covers different types […]
Do you like it?
January 4, 2021
Brief: Cardiovascular disease is a significant health concern worldwide despite having many genomics developments providing valuable new candidates for better biomarkers and novel therapeutic targets. […]
Do you like it?